Skip to content
Home/Companies/Biotech/Ochre Bio

Ochre Bio

Biotech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Ochre Bio?

Ochre Bio is currently owned by Apollo Health Ventures through Apollo Health Ventures Fund II (2021 vintage), since 2021.

Hand-verified · updated 2026-07-03

Apollo Health Ventures
Investor
Apollo Health Ventures
Apollo Health Ventures Fund II · 2021 · Life Sciences VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusActive

More from Apollo Health Ventures Fund II

Other portfolio companies in the same fund.

Therini Bio
Therini Bio
Active
BiotechUS· 2025
Booster Therapeutics
Active
BiotechGermany· 2024
Auron Therapeutics
Auron Therapeutics
Active
BiotechUS· 2022
Cleara Biotech
Cleara Biotech
Active
BiotechNetherlands· 2022
Focal Biosciences
Focal Biosciences
Active
BiotechSwitzerland· 2022
Bloom Science
Bloom Science
Active
BiotechUS· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
Track Ochre Bio

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Ochre Bio?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Ochre Bio.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue